Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross‐sectional study

ConclusionsMeasures of atherosclerotic burden are associated with clinically manifest CVD in subjects with T2D. In addition, vascular changes that are not directly related to known metabolic risk factors are important in the development of both atherosclerosis and CVD in T2D. A better understanding of the mechanisms involved is crucial for enabling better identification of CVD risk in T2D.This article is protected by copyright. All rights reserved.

Source: Journal of Internal Medicine - March 9, 2015 Category: Internal Medicine Authors: Angela C. Shore, Helen M. Colhoun, Andrea Natali, Carlo Palombo, Gerd Östling, Kunihiko Aizawa, Cecilia Kennbäck, Francesco Casanova, Margaretha Persson, Kim Gooding, Phillip E. Gates, Faisel Kahn, Helen C. Looker, Fiona Adams, Jill Belch, Silvia Pinnol Tags: Original Article Source Type: research